Hyperprolactinaemia and the regular menstrual cycle in asymptomatic women: Should it be treated during therapy for infertility?

Reproductive BioMedicine Online

Volumn 11, Issue 5, 2005, Pages 581-588

  Nawroth, Frank ^a  

^a ENDOKRINOLOGIKUM HAMBURG   (Germany)

Author keywords

Hyperprolactinaemia; Macroprolactinaemia; Ovarian stimulation; Prolactin

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN RECEPTOR;

AMENORRHEA; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORPUS LUTEUM FUNCTION; COST BENEFIT ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DRUG ACTIVITY; FEEDBACK SYSTEM; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GALACTORRHEA; HORMONE RELEASE; HUMAN; HYPERPROLACTINEMIA; INCIDENCE; INTRAUTERINE INSEMINATION; LABORATORY DIAGNOSIS; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MOLECULAR WEIGHT; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; OVARY FOLLICLE MATURATION; OVULATION INDUCTION; PROLACTIN BLOOD LEVEL; PROLACTINOMA;

EID: 28244431728     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61166-2     Document Type: Conference Paper

References (75)

1. Andersen AN, Pedersen H, Djursing H et al. 1982 Bioactivity of prolactin in a woman with an excess of large molecular size prolactin, persistent hyperprolactinaemia and spontaneous conception. Fertility and Sterility 38, 625-628.
2. Andino NA, Bidot C, Valdes M et al. 1985 Chromatographic pattern of circulating prolactin in ovulatory hyperprolactinemia. Fertility and Sterility 44, 600-605.
3. Aron D, Howlett T 2000 Pituitary incidentalomas. Endocrinology and Metabolism Clinics of North America 29, 205-221.
4. Astwood EB 1941 The regulation of corpus luteum function by hypophysial luteotrophin. Endocrinology 29, 309-319.
5. Balen AH, Conway GS, Kaltsas G et al. 1995 Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction 10, 2107-2111.
6. Ben-Jonathan N, Mershon JL, Allen DL et al. 1996 Extrapituitary prolactin: distribution, regulation and clinical aspects. Endocrine Reviews 17, 639-669.
7. Bjoro T, Morkrid L, Wergeland R et al. 1995 Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scandinavian Journal of Clinical and Laboratory Investigation 55, 139-147.
8. Bohnet HG, Muhlenstedt D, Hanker JP et al. 1977 Prolactin over-suppression. Archives of Gynaecology 223, 173-178.
9. Bole-Feysot C, Goffin V, Edery M et al. 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews 19, 225-268.
10. Boulanger CM, Mashchak CA, Chang RJ 1985 Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas with bromocriptine. Fertility and Sterility 44, 532-535.
11. Colao A, Di Sarno A, Cappabianca P et al. 2003 Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. New England Journal of Medicine 349, 2023-2033.
12. Clemens JA, Roush ME, Fuller RW 1978 Evidence that serotonin neurons stimulate secretion of prolactin releasing factor. Life Science 22, 2209-2213.
13. Davis JRE 2004 Prolactin and reproductive medicine. Current Opinion in Obstetrics and Gynecology 16, 331-337.
14. Del Pozo E, Wyss H, Tolis G et al. 1979 Prolactin and deficient luteal function. Obstetrics and Gynecology 53, 282-285.
15. De Schepper J, Schiettecatte J, Velkeniers B et al. 2003 Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. European Journal of Endocrinology 149, 201-217.
16. Dunn CL, Kelly RW, Critchley HO 2003 Decidualization of the human endometrial stroma cell: an enigmatic transformation. Reproductive BioMedicine Online 7, 151-161.
17. Escobar-Morreale HF 2004 Macroprolactinemia in women presenting with hyperandrogenic symptoms: implications for the management of polycystic ovary syndrome. Fertility and Sterility 82, 1697-1699.
18. Fahie-Wilson M 2003 In hyperprolactinemia, testing for macroprolactin is essential. Clinical Chemistry 49, 1434-1436.
19. Fahie-Wilson MN, Soule SG 1997 Macroprolactinemia: contribution to hyperprolactinaemia in a distinct general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Annals of Clinical Biochemistry 34, 252-258.
20. Forsyth JA, Wallis M 2002 Growth hormone and prolactin - molecular and functional evolution. Journal of Mammary Gland Biology and Neoplasia 7, 291-312.
21. Foss MC, Paula FJ, Paccola GM et al. 1995 Peripheral glucon metabolism in human hyperprolactinemia. Journal of Clinical Endocrinology 43, 721-726.
22. Gezer A, Atasu T, Hekim C et al. 2005 Hyperprolactinaemia does not always mean 'hyperprolactinaemia'. European Journal of Obstetrics and Gynecology and Reproductive Biology 118, 206-208.
23. Glasow A, Breidert M, Haidan A et al. 1996 Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. Journal of Clinical Endocrinology and Metabolism 81, 3103-3111.
24. Goffin V, Binart N, Touraine P et al. 2002 Prolactin. The new biology of an old hormone. Annual Reviews of Physiology 64, 47-67.
25. Goffin V, Shiverick KT, Kelly PA et al. 1996 Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen and related proteins in mammals. Endocrine Reviews 17, 385-410.
26. Golander A, Hurley T, Barret J et al. 1978 Prolactin synthesis by human chorion-decidual tissue: a possible source of prolactin in the amniotic fluid. Science 202, 311-313.
27. Guitelman M, Colombani-Vidal ME, Zylbersztein CC et al. 2002 Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms. Pituitary 5, 255-260.
28. Hankinson SE, Willett WC, Michaud DS et al. 1999 Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 91, 629-634.
29. Hattori N 2003 Macroprolactinemia: a new cause of hyperprolactinemia. Journal of Pharmacological Sciences 92, 171-177.
30. Hattori N, Inagaki C 1997 Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. Journal of Clinical Endocrinology and Metabolism 82, 3107-3110.
31. Hattori N, Ikekubo K, Nakaya Y et al. 2005 Immunoglobulin G subclasses and prolactin (PRL) isoforms in macroprolactinemia due to anti-PRL autoantibodies. Journal of Clinical Endocrinology and Metabolism 90, 3036-3044.
32. Hauache OM, Rocha AJ, Maia ACM et al. 2002 Screening for macroprolactinaemia and pituitary imaging studies. Clinical Endocrinology 57, 327-331.
33. Jackson RD, Worstman J, Malarkey WB 1985a Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. Journal of Clinical Endocrinology and Metabolism 61, 258-264.
34. Jackson RD, Worstman J, Malarkey WB 1985b Macroprolactinaemia presenting like a pituitary tumor. American Journal of Medicine 78, 346-350.
35. Jacobs LS, Snyder PJ, Wilbur JF et al. 1971 Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. Journal of Clinical Endocrinology and Metabolism 33, 996-998.
36. Katz E, Adashi EY 1990 Hyperprolactinemic disorders. Clinical Obstetrics and Gynecology 33, 622-639.
37. Kaye TB 1996 Hyperprolactinemia. Causes, consequences, and treatment options. Postgraduate Medicine 99, 265-268.
38. Kelly PA, Binart N, Lucas B et al. 2001 Implications of multiple phenotypes observed in prolactin receptor knockout mice. Frontiers in Neuroendocrinology 22, 140-145.
39. Kiapekou E, Loutradis D, Patsoula E et al. 2005 Prolactin receptor mRNA expression in oocytes and preimplantation mouse embryos. Reproductive BioMedicine Online 10, 339-346.
40. Larrea F, Escorza A, Valero A et al. 1989 Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function. Journal of Clinical Endocrinology and Metabolism 68, 982-987.
41. Larrea F, Escorza A, Granados J et al. 1987 Familial occurrence of big-big prolactin as the predominant immunoreactive prolactin species in blood. Fertility and Sterility 47, 956-963.
42. Larrea F, Villanueva C, Cravioto MC et al. 1985 Further evidence that big, big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function. Fertility and Sterility 44, 25-30.
43. Leslie H, Courtney CH, Bell PM et al. 2001 Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. Journal of Clinical Endocrinology and Metabolism 86, 2743-2746.
44. Malarkey WB, Jackson R, Wortsman J 1988 Long-term assessment of patients with macroprolactinemia. Fertility and Sterility 50, 413-418.
45. Maslar IA, Riddick DH 1979 Prolactin production by human endometrium during the normal menstrual cycle. American Journal of Obstetrics and Gynecology 135, 751-754.
46. McNatty KP 1979 Relationship between plasma prolactin and the endocrine microenvironment of the developing human antral follicle. Fertility and Sterility 32, 433-438.
47. McNatty KP, Sawers RS, McNeilly AS 1974 A possible role for prolactin in control of steroid secretion by the Graafian follicle. Nature 250, 653-655.
48. Miyai K, Ichihara K, Kondo K et al. 1986 Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin. Clinical Endocrinology 25, 549-554.
49. Molitch ME 1992 Pathologic hyperprolactinemia. Endocrinology and Metabolism Clinics of North America 21, 877-901.
50. Molitch ME, Thorner MO, Wilson C 1997 Management of prolactinomas. Journal of Clinical Endocrinology and Metabolism 82, 996-1000.
51. Mounier C, Trouillas J, Claustrat B et al. 2003 Macroprolactinemia associated with prolactin adenoma. Human Reproduction 18, 853-857.
52. Noel LG, Suh HK, Stone JG et al. 1972 Human prolactin and growth hormone release during surgery and other conditions of stress. Journal of Clinical Endocrinology and Metabolism 35, 840-851.
53. Olivar AC, Chaffkin LM, Kates RJ et al. 2003 Is it necessary to obtain serum levels of thyroid stimulating hormone and prolactin in asymptomatic women with infertility. Connecticut Medicine 67, 393-395.
54. Olukoga AO 2002 Macroprolactinemia is clinically important. Journal of Clinical Endocrinology and Metabolism 87, 4833-4834.
55. Olukoga AO, Kane JW 1999 Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clinical Endocrinology 51, 119-126.
56. Owerbach D, Rutter WJ, Cooke NE et al. 1981 The prolactin gene is located on chromosome 6 in humans. Science 212, 815-816.
57. Phelbs JY, Bugg EM, Shamblott MJ et al. 2003 Prolactin gene expression in human ovarian follicular cells. Fertility and Sterility 79, 182-185.
58. Posner BI, Kelly PA, Shiu RP et al. 1974 Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology 95, 521-531.
59. Reinthaller A, Bieglmayer C, Deutinger J et al. 1988 Transient hyperprolactinemia during stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment. Fertility and Sterility 49, 432-436.
60. Riddle O, Bates RW, Dykshorn SW 1933 The preparation, identification and assay of prolactin - a hormone of the anterior pituitary. American Journal of Physiology 105, 191-216.
61. Schlechte JA 2003 Prolactinoma. New England Journal of Medicine 349, 2035-2041.
62. Schlechte JA 2002 The macroprolactin problem. Journal of Clinical Endocrinology and Metabolism 87, 5408-5409.
63. Schlechte JA, Sherman B, Martin R 1983 Bone density in amenorrheic women with and without hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism 56, 1120-1123.
64. Scott JZ, Kletzky OA, Brenner PF et al. 1978 Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Fertility and Sterility 30, 141-145.
65. Sinha YN 1995 Structural variants of prolactin: occurrence and physiological significance. Endocrine Reviews 16, 354-396.
66. Smith TP, Suliman AM, Fahie-Wilson MN et al. 2002 Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. Journal of Clinical Endocrinology and Metabolism 87, 5410-5415.
67. Strachan MW, Teoh WL, Don-Wauchope AC et al. 2003 Clinical and radiological features of patients with hyperprolactinaemia. Clinical Endocrinology 59, 339-346.
68. Suliman AM, Smith TP, Gibney J et al. 2003 Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clinical Chemistry 49, 1504-1509.
69. Toldy E, Löcsei Z, Szabolcs I et al. 2003 Macroprolactinemia: the consequences of a laboratory pitfall. Endocrine 22, 267-273.
70. Vallette-Kasic S, Morange-Ramos I, Selim A et al. 2002 Macroprolactinemia revisited: a study on 106 patients. Journal of Clinical Endocrinology and Metabolism 87, 581-588.
71. Vestergaard P, Jorgensen JOL, Hagen C et al. 2002 Fracture risk is increased in patients with GH deficiency or untreated prolactinomas - a case-control study. Clinical Endocrinology 56, 159-167.
72. Vieira JGH, Tachibana TT, Obara LH et al. 1998 Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clinical Chemistry 44, 1758-1759.
73. Whittaker PG, Wilcox T, Lind T 1981 Maintained fertility in a patient with hyperprolactinemia due to big big prolactin. Journal of Clinical Endocrinology and Metabolism 53, 863-866.
74. Yazigi RA, Quintero CH, Salameh WA 1997 Prolactin disorders. Fertility and Sterility 67, 215-225.
75. Yen SS 1980 The polycycstic ovary syndrome. Clinical Endocrinology 12, 177-207.